• What we do
    • Acquisition
    • Divestment
    • Strategy
  • Why Oghma
  • Deals
  • Team
Menu

Cargill completes sale of its cultures and enzymes business to DSM

Posted on December 6, 2012May 9, 2022 by oghma

Oghma Partners is pleased to announce its role as exclusive financial adviser to Cargill BVBA in relation to the following transaction, which was completed on 6 December 2012:

Cargill completes sale of its cultures and enzymes business to DSM

6 December 2012: Cargill has completed the sale of its cultures and enzymes business to Royal DSM. All antitrust clearances have been obtained and the transaction was completed on 6 December 2012.

Note to editors: This transaction was signed and announced on 26 October 2012.  Cargill BVBA announced at that time that it was selling its cultures and enzymes business to Royal DSM, the global life sciences and materials sciences company, in an all cash transaction for a total enterprise value of €85 million.  This sale is in line with Cargill’s strategy to re-focus its texturizing business and concentrate on product lines that are adjacent to the company’s core activities and where it can be a leading or relevant player in the marketplace.

The full press release can be downloaded here.

Categories2012 News, Latest News

Post navigation

Previous PostPrevious Oghma Partners advises McCambridge on Cake Division Disposal
Next PostNext Greencore completes disposal of Minsterley facility to Muller

Recent Posts

  • Oghma advises C.T. Holmes on sale to Brasmar Group
  • UK Food & Beverage M&A – Still A Number of Headwinds Impacting M&A Activity Into 2023
  • Fragmented Market provides opportunities in European Food Ingredients M&A
  • UK Food & Beverage M&A – Deal Volume Continues To Decline
  • Venture Activity in Food & Drink – Early stage investment in the UK Food & Drink Industry 2012-22

Recent Comments

No comments to show.

Oghma Partners LLP

49 Grosvenor Street
Mayfair
London
W1K 3HP

+44 (0) 20 8049 2200
info@oghmapartners.com
2023 Oghma Partners LLP. All rights reserved
Terms of Use Privacy Policy Cookie Policy

    Contact Michael Booth

    • What we do
      • Acquisition
      • Divestment
      • Strategy
    • Why Oghma
    • Deals
    • Team
    • News
    • M&A Review
    • Contact us
    +44 (0) 20 8049 2200 info@oghmapartners.com
    • Oghma auf Deutsch
    • Oghma en español
    • Oghma en français